Natera appoints Monica Bertagnolli to Board of Directors

Natera, Inc.

Board increased from 10 to 11; Bertagnolli appointed as Class III director, term expiring at 2027 annual meeting.
She previously served from Nov 2020 to Aug 2022 before becoming Director of the National Cancer Institute.
She is independent and appointed to Nominating, Corporate Governance and Compliance Committee.
Compensation consistent with other non-employee directors; initial equity award vests over three years.
Indemnification agreement entered into with Bertagnolli.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Monica Bertagnolli

member of the Board

NTRA · Natera, Inc.

Effective: 2025-03-06
Filed: March 12, 2025, 7:59 PM ET

appointed Monica Bertagnolli as a member of the Board, in each case effective as of March 6, 2025.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Monica Bertagnolli was appointed as member of the Board at Natera, Inc..

Action: appointed
Role: member of the Board

Exact text from the filing

appointed Monica Bertagnolli as a member of the Board, in each case effective as of March 6, 2025.

View on SEC.gov

Natera, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-25-022968

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.